Literature DB >> 11761177

Increasing hydroxyapatite incorporation into poly(methylmethacrylate) cement increases osteoblast adhesion and response.

M J Dalby1, L Di Silvio, E J Harper, W Bonfield.   

Abstract

Poly(methylmethacrylate) (PMMA) is the current standard for cement held prostheses. It forms a strong bond with the implant, but the bond between the cement and the bone is considered to be weak, with fibroblastic cells observed at the implant site, rather than direct bone contact, a contributing factor leading to implant failure. Incorporation of hydroxyapatite (HA) increases the biological response to the cement from tissue around the implant site, thus giving increased bone apposition. In this study, PMMA discs with 0, 4.6 and 8.8 vol%. HA were examined. Primary human osteoblast-like cells (HOBs) were used for the biological evaluation of the response to the cements in vitro. Morphology was observed using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). Measurement of tritiated thymidine (3H-TdR) incorporation and alkaline phosphatase (ALP) activity were used to assess proliferation and differentiation. A synergy between increasing focal contact formation, cytoskeletal organisation, cell proliferation and expression of phenotype was observed with increasing HA volume. Preferential anchorage of HOBs to HA rather than PMMA was a prominent observation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11761177     DOI: 10.1016/s0142-9612(01)00139-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  25 in total

1.  In vitro assessment of the biological response to nano-sized hydroxyapatite.

Authors:  J Huang; S M Best; W Bonfield; R A Brooks; N Rushton; S N Jayasinghe; M J Edirisinghe
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

2.  Mesenchymal stem cell (MSC) and endothelial progenitor cell (EPC) growth and adhesion in six different bone graft substitutes.

Authors:  J Schultheiss; C Seebach; D Henrich; K Wilhelm; J H Barker; J Frank
Journal:  Eur J Trauma Emerg Surg       Date:  2011-06-07       Impact factor: 3.693

Review 3.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

4.  The effect of partially stabilized zirconia on the biological properties of HA/HDPE composites in vitro.

Authors:  A Yari Sadi; M A Shokrgozar; S Sh Homaeigohar; M Hosseinalipour; A Khavandi; J Javadpour
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

5.  The effect of surface treatment of hydroxyapatite on the properties of a bioactive bone cement.

Authors:  J A Roether; S Deb
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

6.  [Biocompatibility of polymer-bioglass cement Cortoss®: in vitro test with the MG63 cell model].

Authors:  C Fölsch; R Pinkernell; R Stiletto
Journal:  Orthopade       Date:  2013-03       Impact factor: 1.087

7.  Biological evaluation of partially stabilized zirconia added HA/HDPE composites with osteoblast and fibroblast cell lines.

Authors:  Amir Yari Sadi; Mohammad Ali Shokrgozar; Seyed Shahin Homaeigohar; Alireza Khavandi
Journal:  J Mater Sci Mater Med       Date:  2007-12-23       Impact factor: 3.896

8.  Development of nano-sized hydroxyapatite reinforced composites for tissue engineering scaffolds.

Authors:  Jie Huang; Yu Wan Lin; Xiao Wei Fu; Serena M Best; Roger A Brooks; Neil Rushton; William Bonfield
Journal:  J Mater Sci Mater Med       Date:  2007-09-20       Impact factor: 3.896

9.  Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Formulation and rheological behaviour.

Authors:  L Hernández; M Gurruchaga; I Goñi
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

10.  Controllable porosity hydroxyapatite ceramics as spine cage: fabrication and properties evaluation.

Authors:  W W Lu; F Zhao; K D K Luk; Y J Yin; K M C Cheung; G X Cheng; K D Yao; J C Y Leong
Journal:  J Mater Sci Mater Med       Date:  2003-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.